Pharmacogenetic testing revisited: 5′ nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19

Due to their involvement in the metabolization of commonly prescribed psychopharmaceutical drugs, the cytochrome oxidase genes CYP2D6 and CYP2C19 are extensive targets for pharmacogenetic testing. The existence of common allelic variants allows the prediction of a metabolic phenotype based on a geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Jens Borggaard, Rasmussen, Jan Borg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403119/
https://www.ncbi.nlm.nih.gov/pubmed/28458572
http://dx.doi.org/10.2147/PGPM.S131580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403119/
https://www.ncbi.nlm.nih.gov/pubmed/28458572
http://dx.doi.org/10.2147/PGPM.S131580

Ejemplares similares